- Hyaluronic Acid,
- Botulinum Toxin,
- Collagen,
- Others
South Korea dermal fillers market was valued at USD x million in 2022 and is expected to grow at x% Compound Annual Growth Rate (CAGR) from 2023 to 2029. Dermal fillers are injectable implants which are also known as wrinkle fillers or soft tissue fillers. The dermal fillers diminish the facial lines and help restore the volume of the face. With the aging, the facial muscles lose the subcutaneous fat. Factors such as sun exposure and heredity are also affecting the dermal fillers market in South Korea. Dermal fillers are medical devices approved by the Food and Drug Administration (FDA) for use in cosmetic procedures. The market is expected to grow in the forecasted period.
In January 2017, Allergan Launched Juvéderm Volite - an Innovative Injectable Treatment Designed to Improve Skin Quality for up to 9 Months
The raising beauty conscious is increasing the demand of dermal filling. The growing awareness among the people regarding the modern cosmetic procedures and shift from the invasive to the minimally invasive and the non-invasive procedures are majorly enhancing the growth of the market. The increasing use of anti-ageing treatments and technological advancements are likely to drive the growth of the Market. However, the high cost involved in the procedure is hampering the growth of the market.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.